Comparison Between Levosimendan & Adrenaline in CABG Patients

Status Not yet recruiting

Clinical Trial Summary

The aim of this study is to compare between levosimendan and adrenaline in patients with pre-existing impaired systolic function (EF 30-40%), undergoing elective on-pump CABG, as regards hemodynamics and echocardiographic parameters.

Clinical Trial Description

Patients undergoing cardiac surgery are at risk of post-cardiotomy myocardial dysfunction. This condition causes delayed recovery, organ failure, prolonged intensive care unit and hospital stays, and an increased risk of mortality. These patients often require inotropic support, which has been associated with an increased risk of cardiovascular complications. Treatment of myocardial dysfunction includes optimization of myocardial contractility through appropriate fluid and pharmacologic management and mechanical support . Extensive use of inotropes in this situation is needed, but the optimal pharmacologic management of myocardial dysfunction in cardiac surgery is a matter of ongoing debate .Available inotropes including adrenaline may increase myocardial oxygen consumption, heart rate and risk of arrhythmia. An increase in myocardial oxygen consumption by inotropes in a state of inadequate oxygen delivery may further deteriorate underlying cardiac dysfunction and even lead to increased mortality . There are questions regarding the ideal inotrope to use during the post cardiopulmonary bypass (CPB) period in patients undergoing on-pump CABG surgery. The occurrence of myocardial dysfunction after cardiac surgery is a potential indication for the use of levosimendan, a calcium sensitizer with a unique mechanism of action. By binding to cardiac troponin C, it enhances myofilament responsiveness to calcium, thereby increasing myocardial contraction without increasing myocardial oxygen consumption. In addition, levosimendan activates adenosine triphosphate-dependent potassium channels, which are important mediators of ischemic and anesthetic cardioprotection. Levosimendan might thus have a potential benefit for patients with myocardial oxygen imbalance requiring inotropic drug support . The hypothesis of the present study is that levosimendan without loading dose can improve myocardial function and provide better hemodynamics as well as echocardiographic parameters compared with adrenaline in patients with low ejection fraction undergoing op-pump CABG ;

Study Design

Related Conditions & MeSH terms

Open Heart Surgery

Clinical Trial Details

NCT number	NCT05222256
Study type	Interventional
Source	Assiut University
Contact	Abdelrahman Mohamed Abdelhafeez
Phone	00201112272212
Email	feezoo15@gmail.com
Status	Not yet recruiting
Phase	N/A
Start date	March 2022
Completion date	May 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06203184` - The Effect of Video Game-Based Exercises After Open Heart Surgery	N/A
Not yet recruiting	`NCT03806413` - Post-surgical Delirium in Patients Undergoing Open Heart Surgery.
Recruiting	`NCT04670367` - The Effects of Baduanjin Exercise on Meridian Energy and Heart Rate Variability in Patients Undergoing Cardiac Sugery	N/A
Terminated	`NCT04506762` - Benefit of Peri-operative Bilateral ESP Catheters for Enhanced Recovery for Cardiac Surgery (ERCS)	N/A
Completed	`NCT05316207` - Tele-Nursing Follow-Up After Open Heart Surgery	N/A
Completed	`NCT06436872` - The Effect of Informing the Relatives of Patients Undergoing Open Heart Surgery	N/A
Recruiting	`NCT05441358` - Assessment of Platelet Function in Patients Undergoing Open Heart Surgery
Not yet recruiting	`NCT05715060` - Sternal Closure in Children After Cardiac Surgery	N/A
Completed	`NCT03105089` - Effect of Cardiac Preconditioning Upon the Inotrope Score	N/A
Completed	`NCT05149235` - Gaming Technology and Cardiac Rehabilitation	N/A
Completed	`NCT03106818` - Postoperative Pain Alleviation in Open Heart Surgery	N/A
Completed	`NCT04486690` - Neuroprotection During Open Heart Surgery	Phase 3
Completed	`NCT01069562` - Closed Loop Isoflurane Administration With Bispectral Index in Open Heart Surgery	N/A
Recruiting	`NCT05522712` - Acapella Versus Incentive Spirometer on Cardiopulmonary Fitness After Heart Valve Surgery.	N/A
Completed	`NCT04213040` - Procalcitonin and Postoperative Outcome After Open-heart Surgery
Completed	`NCT06165861` - The Effect of Using Virtual Reality Glasses on Surgical Fear and Anxiety	N/A
Active, not recruiting	`NCT03955536` - Comparison of the Effects of Different Physiotherapy and Rehabilitation Methods on Open Heart Surgery	N/A
Recruiting	`NCT06168799` - Ilofotase Alfa for Prevention of Renal Damage After Cardiac Surgery	Phase 2
Recruiting	`NCT03799965` - The Effect of Advanced Improvement Program (ERAS) on Postoperative Outcomes in Patients Undergoing Open Heart Surgery	N/A
Completed	`NCT05932368` - Early Evaluation After Cardiac Surgery

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Comparison Between Levosimendan and Adrenaline in CABG Patients

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms